Researchers have identified a distinct and reproducible gene expression program associated with neurotransmission in the ...

Newly discovered drug leverages the power of Pattern Discovery Engine™ (PDE) and is an extension of 2025 study wherein Pattern developed novel risk assessment tool, discovered new drug target for ...

Four-way collaboration brings together world-leading AI and biological expertise to make AI-predicted protein complex structures openly available to ...

Scientists have long observed that embryos of different species within a phylum look quite distinct at early and late ...

The following Naperville residents have completed college/university degrees or have been named to their school’s dean’s list ...

New collaboration aims to bring population-scale whole-genome sequencing into everyday healthcare, enabling earlier risk detection and data-driven prevention SAN DIEGO ...

Leveraging Authentic Data for Life Science Breakthroughs. Reproducibility is one of the most urgent challenges in life science research. Irreproducible results are often driven by unauthenti ...

Translational bioinformatics lies at the intersection of computational biology, multi-omics, and clinical data science, offering a powerful toolkit for ...

In life sciences, enterprise value only emerges when generative AI is treated as a business capability and embedded into existing operating models.

When Rosie, an eight-year-old rescue dog, was diagnosed with aggressive cancer, her owner feared the worst. Surgery and ...

A Sydney data engineer has developed the world's first personalised mRNA cancer vaccine for a dog using AI tools like ChatGPT ...

Learn more about whether Revvity, Inc. or 10x Genomics, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.